IP Library › Granted Patent US 8,519,186
Granted Patent B2
US 8,519,186 · App. 12/914,645 · Granted Aug 27, 2013

Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors

Inventors: Kirill A. Lukin (Vernon Hills, IL); Margaret Chi-Ping Hsu (Lake Forest, IL); Dilinie P. Fernando (Groton, CT); Brian J. Kotecki (Oak Creek, WI); Marvin R. Leanna (Grayslake, IL)
Assignee: AbbVie Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,519,186
App. No.
12/914,645
Granted
Aug 27, 2013
Kind
B2
Abstract

The present invention relates to a process of preparing indazolyl ureas that are useful as antagonists of the vanilloid receptor subtype 1 (VR1).

Claims (4)

1. A compound of formula (III),

wherein R 9 , R 11 , and R 12 are each hydrogen; and

R 10 is selected from the group consisting of alkyl, alkoxy, halogen, hydroxy, cyano, and nitro.

2. A compound of formula (XI),

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030231/0808 →
Continuity (3)
Division 11734900 · Apr 13, 2007
Provisional Application 60792099 · Apr 14, 2006
Related Publication 20110040102A1 · Feb 17, 2011